Arcutis Biotherapeutics Inc (ARQT)
EBITDA
$17.15M
Quarterly · Period ending: · USD
ARQT EBITDA
Latest reported$17.15Mperiod ending
Latest reported$17.15Mperiod ending
ARQT Quarterly EBITDA ($500.00 → $17.15M)
Quarterly EBITDA
High-resolution chart · PNG
ARQT ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 17,149,000 | |
| -6,272,000 | |
| 21,429,000 | |
| 11,123,000 | |
| -11,952,000 | |
| -18,667,000 | |
| -4,456,000 | |
| -33,613,000 | |
| -44,831,000 | |
| -27,220,000 | |
| -58,112,000 | |
| -33,796,000 | |
| -63,256,000 | |
| -72,695,000 | |
| -64,757,000 | |
| -102,528,000 | |
| -65,251,000 | |
| -62,336,000 | |
| -71,190,000 | |
| -56,864,000 | |
| -41,904,000 | |
| -35,944,000 | |
| -34,029,000 | |
| -38,273,000 | |
| -35,382,000 | |
| -27,986,000 | |
| -12,417,000 | |
| -14,629,000 | |
| -8,537,000 | |
| -6,928,000 | |
| 0 | |
| 20,000 | |
| 500 | |
| 500 |